Regulation of Aicda expression and AID activity

Autoimmunity

Volumn 46, Issue 2, 2013, Pages 83-101

  Zan, Hong ^a   Casali, Paolo ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

14 3 3; Activation induced cytidine deaminase (AID); Antibody; Autoantibody; Class switch DNA recombination (CSR); HoxC4; Mutagenesis; NF B; Somatic hypermutation (SHM)

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; ADAPTOR PROTEIN; DEOXYCYTIDINE; ESTROGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 4; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ALLERGY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; AUTOIMMUNITY; B LYMPHOCYTE DIFFERENTIATION; CARCINOGENESIS; CROSS LINKING; DNA RECOMBINATION; ENZYME ACTIVITY; EPIGENETICS; GENE LOCUS; HUMAN; INFLAMMATION; MEMORY CELL; MUTAGENIC ACTIVITY; NEOPLASM; NONHUMAN; POINT MUTATION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; SOMATIC HYPERMUTATION; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CYTIDINE DEAMINASE; ENZYME ACTIVATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA INTERFERENCE; RNA PROCESSING, POST-TRANSCRIPTIONAL; TRANSCRIPTION, GENETIC;

EID: 84873692363     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.749244     Document Type: Review

References (161)

1. Xu, Z., H. Zan, E. J. Pone, T. Mai, and P. Casali. 2012. Immunoglobulin class switching: induction, targeting and beyond. Nature Rev. Immunol. 12: 517-531
2. Zan, H., C. A. White, L. M. Thomas, et al. 2012. Rev1 recruits Ung to switch regions and enhances dU deglycosylation for immunoglobulin class switch DNA recombination. Cell Repts. 2: 1220-1232
3. Marusawa, H., and T. Chiba. 2010. Helicobacter pyloriinduced activation-induced cytidine deaminase expression and carcinogenesis. Curr. Opin. Immunol. 22: 442-447
4. Marusawa, H., A. Takai, and T. Chiba. 2011. Role of activation-induced cytidine deaminase in inflammationassociated cancer development. Adv. Immunol. 111: 109-141
5. Xu, Z., E. J. Pone, A. Al-Qahtani, et al. 2007. Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination. Crit. Rev. Immunol. 27: 367-397
6. Stavnezer, J. 2011. Complex regulation and function of activation-induced cytidine deaminase. Trends Immunol. 32: 194-201
7. Kuraoka, M., T. M. Holl, D. Liao, et al. 2011. Activationinduced cytidine deaminase mediates central tolerance in B cells. Proc. Natl. Acad. Sci. USA 108: 11560-11565
8. Meyers, G., Y. S. Ng, J. M. Bannock, et al. 2011. Activationinduced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc. Natl. Acad. Sci. USA 108: 11554-11559
9. Pasqualucci, L., G. Bhagat, M. Jankovic, et al. 2008. AID is required for germinal center-derived lymphomagenesis. Nat. Genet. 40: 108-112
10. Robbiani, D. F., S. Bunting, N. Feldhahn, et al. 2009. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol. Cell 36: 631-641
11. Hasham, M. G., N. M. Donghia, E. Coffey, et al. 2010. Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination. Nat. Immunol. 11: 820-826
12. Ramiro, A. R., M. Jankovic, T. Eisenreich, et al. 2004. AID is required for c-Myc/IgH chromosome translocations in vivo. Cell 118: 431-438
13. Robbiani, D. F., A. Bothmer, E. Callen, et al. 2008. AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 135: 1028-1038
14. Delker, R. K., S. D. Fugmann, and F. N. Papavasiliou. 2009. A coming-of-age story: activation-induced cytidine deaminase turns 10. Nat. Immunol. 10: 1147-1153
15. Hasler, J., C. Rada, and M. S. Neuberger. 2011. Cytoplasmic activation-induced cytidine deaminase (AID) exists in stoichiometric complex with translation elongation factor 1a (eEF1A). Proc. Natl. Acad. Sci. USA 108: 18366-18371
16. Aoufouchi, S., A. Faili, C. Zober, et al. 2008. Proteasomal degradation restricts the nuclear lifespan of AID. J. Exp.Med. 205: 1357-1368
17. Uchimura, Y., L. F. Barton, C. Rada, and M. S. Neuberger. 2011. REG-g associates with and modulates the abundance of nuclear activation-induced deaminase. J. Exp. Med. 208: 2385-2891
18. Li, G., E. J. Pone, T. Mai, et al. 2012. Iron inhibits activation-induced cytidine deaminase enzymatic activity and modulates immunoglobulin class switch DNA recombination. J. Biol. Chem. 287: 21520-21529
19. Shinkura, R., S. Ito, N. A. Begum, et al. 2004. Separate domains of AID are required for somatic hypermutation and class-switch recombination. Nat. Immunol. 5: 707-712
20. Pone, E. J., J. Zhang, T. Mai, et al. 2012. BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-kB pathway. Nat. Commun. 3: 767
21. Bishop, G. A., and B. S. Hostager. 2003. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev. 14: 297-309
22. Graham, J. P., K. M. Arcipowski, and G. A. Bishop. 2010. Differential B-lymphocyte regulation by CD40 and its viral mimic, latent membrane protein 1. Immunol. Rev. 237: 226-248
23. Rickert, R. C., J. Jellusova, and A. V. Miletic. 2011. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease. Immunol. Rev. 244: 115-133
24. Oeckinghaus, A., M. S. Hayden, and S. Ghosh. 2011. Crosstalk in NF-kB signaling pathways. Nat. Immunol. 12: 695-708
25. Sun, S. C. 2011. Non-canonical NF-kB signaling pathway. Cell Res. 21: 71-85
26. Tran, T. H., M. Nakata, K. Suzuki, et al. 2010. B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers. Nat. Immunol. 11: 148-154
27. Cerutti, A. 2008. The regulation of IgA class switching. Nat. Rev. Immunol. 8: 421-434
28. Fagarasan, S., S. Kawamoto, O. Kanagawa, and K. Suzuki. 2010. Adaptive immune regulation in the gut: T celldependent and T cell-independent IgA synthesis. Annu. Rev. Immunol. 28: 243-273
29. Cerutti, A., K. Chen, and A. Chorny. 2011. Immunoglobulin responses at the mucosal interfaces. Annu. Rev. Immunol. 29: 273-293
30. Bossen, C., and P. Schneider. 2006. BAFF, APRIL and their receptors: structure, function and signaling. Semin. Immunol. 18: 263-275
31. Mackay, F., and P. Schneider. 2009. Cracking the BAFF code. Nat. Rev. Immunol. 9: 491-502
32. He, B., X. Qiao, and A. Cerutti. 2004. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J. Immunol. 173: 4479-4491
33. Xu, W., P. A. Santini, A. J. Matthews, et al. 2008. Viral double-stranded RNA triggers Ig class switching by activating upper respiratory mucosa B cells through an innate TLR3 pathway involving BAFF. J. Immunol. 181: 276-287
34. He, B., R. Santamaria, W. Xu, et al. 2010. The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat. Immunol. 11: 836-845
35. Bombardieri, M., N. W. Kam, F. Brentano, et al. 2011. A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Ann. Rheum. Dis. 70: 1857-1865
36. Vos, Q., A. Lees, Z. Q. Wu, C. M. Snapper, and J. J. Mond. 2000. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 176: 154-170
37. Coutinho, A., and A. Poltorack. 2003. Innate immunity: from lymphocyte mitogens to Toll-like receptors and back. Curr. Opin. Immunol. 15: 599-602
38. Pone, E. J., H. Zan, J. Zhang, et al. 2010. Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responses. Crit. Rev. Immunol. 30: 1-29
39. Pone, E. J., Z. Xu, C. A. White, H. Zan, and P. Casali. 2012. B cell TLRs and induction of immunoglobulin class-switch DNA recombination. Front. Biosci. 17: 2594-2615
40. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826
41. Lee, M. S., and Y. J. Kim. 2007. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu. Rev. Biochem. 76: 447-480
42. Kawai, T., and S. Akira. 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21: 317-337
43. Gururajan, M., J. Jacob, and B. Pulendran. 2007. Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets. PLoS One 2: e863
44. Coutinho, A., and G. Moller. 1975. Thymus-independent Bcell induction and paralysis. Adv. Immunol. 21: 113-236
45. Pike, B. L., M. R. Alderson, and G. J. Nossal. 1987. Tindependent activation of single B cells: an orderly analysis of overlapping stages in the activation pathway. Immunol. Rev. 99: 119-152
46. Medzhitov, R., P. Preston-Hurlburt, and C. A. Janeway, Jr. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397
47. Poltorak, A., X. He, I. Smirnova, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088
48. Poxton, I. R. 1995. Antibodies to lipopolysaccharide. J. Immunol. Meth. 186: 1-15
49. Quintana, F. J., A. Solomon, I. R. Cohen, and G. Nussbaum. 2008. Induction of IgG3 to LPS via Toll-like receptor 4 co-stimulation. PLoS One 3: e3509
50. Chaturvedi, A., D. Dorward, and S. K. Pierce. 2008. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity 28: 799-809
51. Chaturvedi, A., and S. K. Pierce. 2009. How location governs Toll-like receptor signaling. Traffic 10: 621-628
52. Gu, X., V. Shivarov, and M. P. Strout. 2012. The role of activation-induced cytidine deaminase in lymphomagenesis. Curr. Opin. Hematol. 19: 292-298
53. Sernández, I. V., V. G. de Yébenes, Y. Dorsett, and A. R. Ramiro. 2008. Haploinsufficiency of activationinduced deaminase for antibody diversification and chromosome translocations both in vitro and in vivo. PLoS One 3: e3927
54. Takizawa, M., H. Tolarova, Z. Li, et al. 2008. AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development. J. Exp. Med. 205: 1949-1957
55. Zan, H., J. Zhang, S. Ardeshna, et al. 2009. Lupus-prone MRL/Fas lpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent up-regulation of somatic hypermutation and class switch DNA recombination. Autoimmunity 42: 89-103
56. Rush, J. S., M. Liu, V. H. Odegard, S. Unniraman, and D. G. Schatz. 2005. Expression of activation-induced cytidine deaminase is regulated by cell division, providing a mechanistic basis for division-linked class switch recombination. Proc. Natl. Acad. Sci. USA 102: 13242-13247
57. Rawlings, D. J., M. A. Schwartz, S. W. Jackson, and A. Meyer-Bahlburg. 2012. Integration of B cell responses through Toll-like receptors and antigen receptors. Nat. Rev. Immunol. 12: 282-294
58. Zarnegar, B., J. Q. He, G. Oganesyan, et al. 2004. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-kB activation pathways. Proc. Natl. Acad. Sci. USA 101: 8108-8113
59. Park, S. R., H. Zan, Z. Pal, et al. 2009. HoxC4 binds to the promoter of the cytidine deaminase AID gene to induce AID expression, class-switch DNA recombination and somatic hypermutation. Nat. Immunol. 10: 540-550
60. Smale, S. T. 2011. Hierarchies of NF-kB target-gene regulation. Nat. Immunol. 12: 689-694
61. Baltimore, D. 2011. NF-kB is 25. Nat. Immunol. 12: 683-685
62. Sayegh, C. E., M. W. Quong, Y. Agata, and C. Murre. 2003. E-proteins directly regulate expression of activation-induced deaminase in mature B cells. Nat. Immunol. 4: 586-593
63. Ise, W., M. Kohyama, B. U. Schraml, et al. 2011. The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat. Immunol. 12: 536-543
64. Pritchard, C. C., H. H. Cheng, and M. Tewari. 2012. MicroRNA profiling: approaches and considerations. Nat. Rev. Genet. 13: 358-369
65. Teng, G., P. Hakimpour, P. Landgraf, et al. 2008. MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28: 621-629
66. Dorsett, Y., K. M. McBride, M. Jankovic, et al. 2008. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-IgH translocation. Immunity 28: 630-638
67. de Yébenes, V. G., L. Belver, D. G. Pisano, et al. 2008. miR-181b negatively regulates activation-induced cytidine deaminase in B cells. J. Exp. Med. 205: 2199-2206
68. Borchert, G. M., N. W. Holton, and E. D. Larson. 2011. Repression of human activation induced cytidine deaminase by miR-93 and miR-155. BMC Cancer 10: 347
69. Basso, K., C. Schneider, Q. Shen, et al. 2012. Bc16 positively regulates AID and germinal center gene expression via repression of miR-155. J. Exp. Med. 209: 2455-2465
70. Thai, T. H., D. P. Calado, S. Casola, et al. 2007. Regulation of the germinal center response by microRNA-155. Science 316: 604-608
71. Landgraf, P., M. Rusu, R. Sheridan, et al. 2007. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414
72. Kluiver, J., A. van den Berg, D. de Jong, et al. 2007. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene 26: 3769-3776
73. Ito, S., H. Nagaoka, R. Shinkura, et al. 2004. Activationinduced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1. Proc. Natl. Acad. Sci. USA 101: 1975-1980
74. Cattoretti, G., M. Buttner, R. Shaknovich, et al. 2006. Nuclear and cytoplasmic AID in extrafollicular and germinal center B cells. Blood 107: 3967-3975
75. Pasqualucci, L., R. Guglielmino, J. Houldsworth, et al. 2004. Expression of the AID protein in normal and neoplastic B cells. Blood 104: 3318-3325
76. McBride, K. M., V. Barreto, A. R. Ramiro, P. Stavropoulos, and M. C. Nussenzweig. 2004. Somatic hypermutation is limited by CRM1-dependent nuclear export of activationinduced deaminase. J. Exp. Med. 199: 1235-1244
77. Brar, S. S., M. Watson, and M. Diaz. 2004. Activationinduced cytosine deaminase (AID) is actively exported out of the nucleus but retained by the induction of DNA breaks. J. Biol. Chem. 279: 26395-26401
78. Zaprazna, K., and M. L. Atchison. 2012. YY1 controls immunoglobulin class switch recombination and nuclear activation-induced deaminase levels. Mol. Cell. Biol. 32: 1542-1554
79. Häsler, J., C. Rada, and M. S. Neuberger. 2012. The cytoplasmic AID complex. Semin. Immunol. 24: 273-280
80. Orthwein, A., A. M. Patenaude, el B. Affar, et al. 2010. Regulation of activation-induced deaminase stability and antibody gene diversification by Hsp90. J. Exp. Med. 207: 2751-2765
81. Orthwein, A., A. Zahn, S. P. Methot, et al. 2011. Optimal functional levels of activation-induced deaminase specifically require the Hsp40 DnaJa1. EMBO J. 31: 679-691
82. Chaudhuri, J., C. Khuong, and F. W. Alt. 2004. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets. Nature 430: 992-998
83. Basu, U., J. Chaudhuri, C. Alpert, et al. 2005. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation. Nature 438: 508-511
84. McBride, K. M., A. Gazumyan, E. M. Woo, et al. 2006. Regulation of hypermutation by activation-induced cytidine deaminase phosphorylation. Proc. Natl. Acad. Sci. USA 103: 8798-8803
85. Pasqualucci, L., Y. Kitaura, H. Gu, and R. Dalla-Favera. 2006. PKA-mediated phosphorylation regulates the function of activation-induced deaminase (AID) in B cells. Proc. Natl. Acad. Sci. USA 103: 395-400
86. Ramiro, A. R., P. Stavropoulos, M. Jankovic, and M. C. Nussenzweig. 2003. Transcription enhances AID-mediated cytidine deamination by exposing single-stranded DNA on the nontemplate strand. Nat. Immunol. 4: 452-456
87. Shinkura, R., M. Tian, M. Smith, et al. 2003. The influence of transcriptional orientation on endogenous switch region function. Nat. Immunol. 4: 435-441
88. Yu, K., F. Chedin, C. L. Hsieh, T. E. Wilson, and M. R. Lieber. 2003. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat. Immunol. 4: 442-451
89. Nambu, Y., M. Sugai, H. Gonda, et al. 2003. Transcriptioncoupled events associating with immunoglobulin switch region chromatin. Science 302: 2137-2140
90. Liu, M., J. L. Duke, D. J. Richter, et al. 2008. Two levels of protection for the B cell genome during somatic hypermutation. Nature 451: 841-845
91. Staszewski, O., R. E. Baker, A. J. Ucher, et al. 2011. Activation-induced cytidine deaminase induces reproducible DNA breaks at many non-Ig Loci in activated B cells. Mol. Cell 41: 232-242
92. Klein, I. A., W. Resch, M. Jankovic, et al. 2011. Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 147: 95-106
93. Chiarle, R., Y. Zhang, R. L. Frock, et al. 2011. Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell 147: 107-119
94. Xu, Z., Z. Fulop, G.Wu, et al. 2010. 14-3-3 adaptor proteins recruit AID to 50-AGCT-30-rich switch regions for class switch recombination. Nature Struct. Mol. Biol. 17: 1124-1135
95. Shen, H. M., M. G. Poirier, M. J. Allen, et al. 2009. The activation-induced cytidine deaminase (AID) efficiently targets DNA in nucleosomes but only during transcription. J. Exp. Med. 206: 1057-1071
96. Conticello, S. G., K. Ganesh, K. Xue, et al. 2008. Interaction between antibody-diversification enzyme AID and spliceosome-associated factor CTNNBL1. Mol. Cell 31: 474-484
97. Pavri, R., A. Gazumyan, M. Jankovic, et al. 2010. Activationinduced cytidine deaminase targets DNA at sites of RNA polymerase II stalling by interaction with Spt5. Cell 143: 122-133
98. Maeda, K., S. K. Singh, K. Eda, et al. 2010. GANP-mediated recruitment of activation-induced cytidine deaminase to cell nuclei and to immunoglobulin variable region DNA. J. Biol. Chem. 285: 23945-23953
99. Okazaki, I. M., K. Okawa, M. Kobayashi, et al. 2011. Histone chaperone Spt6 is required for class switch recombination but not somatic hypermutation. Proc. Natl. Acad. Sci. USA 108: 7920-7925
100. Nowak, U., A. J. Matthews, S. Zheng, and J. Chaudhuri. 2011. The splicing regulator PTBP2 interacts with the cytidine deaminase AID and promotes binding of AID to switch-region DNA. Nat. Immunol. 12: 160-166
101. Basu, U., F. L. Meng, C. Keim, et al. 2011. The RNA exosome targets the AID cytidine deaminase to both strands of transcribed duplex DNA substrates. Cell 144: 353-363
102. Stanlie, A., M. Aida, M. Muramatsu, T. Honjo, and N. A. Begum. 2010. Histone3 lysine4 trimethylation regulated by the facilitates chromatin transcription complex is critical for DNA cleavage in class switch recombination. Proc. Natl. Acad. Sci. USA 107: 22190-22195
103. Willmann, K. L., S. Milosevic, S. Pauklin, et al. 2012. A role for the RNA pol II-associated PAF complex in AID-induced immune diversification. J. Exp. Med. 209: 2099-2111
104. Yamane, A.,W. Resch, N. Kuo, et al. 2011. Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat. Immunol. 12: 62-69
105. Xue, K., C. Rada, and M. S. Neuberger. 2006. The in vivo pattern of AID targeting to immunoglobulin switch regions deduced from mutation spectra in msh2-/-ung-/-mice. J. Exp. Med. 203: 2085-2094
106. Tafvizi, A., F. Huang, A. R. Fersht, L. A. Mirny, and A. M. van Oijen. 2011. A single-molecule characterization of p53 search on DNA. Proc. Natl. Acad. Sci. USA 108: 563-568
107. Wang, L., R. Wuerffel, S. Feldman, A. A. Khamlichi, and A. L. Kenter. 2009. S region sequence, RNA polymerase II, and histone modifications create chromatin accessibility during class switch recombination. J. Exp. Med. 206: 1817-1830
108. Rajagopal, D., R. W. Maul, A. Ghosh, et al. 2009. Immunoglobulin switch mu sequence causes RNA polymerase II accumulation and reduces dA hypermutation. J. Exp. Med. 206: 1237-1244
109. Li, G., E. J. Pone, T. Mai, et al. 2012. Combinatorial H3K9acS10ph histone modifications target 14-3-3 adaptors and AID for class switch DNA recombination, Submitted
110. Li, G., H. Zan, Z. Xu, and P. Casali. 2012. Epigenetics of the antibody response. Trends Immunol., In press
111. Jeevan-Raj, B. P., I. Robert, V. Heyer, et al. 2011. Epigenetic tethering of AID to the donor switch region during immunoglobulin class switch recombination. J. Exp. Med. 208: 1649-1660
112. Begum, N. A., A. Stanlie, M. Nakata, H. Akiyama, and T. Honjo. 2012. The histone chaperone SPT6 is required for AID target determination through H3K4me3 regulation. J. Biol. Chem. 287: 32415-32429
113. Fraenkel, S., R. Mostoslavsky, T. I. Novobrantseva, et al. 2007. Allelic 'choice' governs somatic hypermutation in vivo at the immunoglobulin kappa-chain locus. Nat. Immunol. 8: 715-722
114. Jolly, C. J., and M. S. Neuberger. 2001. Somatic hypermutation of immunoglobulin kappa transgenes: association of mutability with demethylation. Immunol. Cell Biol. 79: 18-22
115. Larijani, M., D. Frieder, T. M. Sonbuchner, et al. 2005. Methylation protects cytidines from AID-mediated deamination. Mol. Immunol. 42: 599-604
116. Odegard, V. H., S. T. Kim, S. M. Anderson, M. J. Shlomchik, and D. G. Schatz. 2005. Histone modifications associated with somatic hypermutation. Immunity 23: 101-110
117. Borchert, G. M., N. W. Holton, K. A. Edwards, L. A. Vogel, and E. D. Larson. 2010. Histone H2A and H2B are monoubiquitinated at AID-targeted loci. PLoS One 5: e11641
118. Vuong, B. Q., M. Lee, S. Kabir, et al. 2009. Specific recruitment of protein kinase A to the immunoglobulin locus regulates class-switch recombination. Nat. Immunol. 10: 420-426
119. Golenser, J., A. Domb, T. Mordechai-Daniel, et al. 2006. Iron chelators: correlation between effects on Plasmodium spp. and immune functions. J. Parasitol. 92: 170-177
120. Swingler, S., J. Zhou, C. Swingler, et al. 2008. Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS. Cell Host Microbe 4: 63-76
121. Barton, J. C., L. F. Bertoli, and R. T. Acton. 2003. Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282Y. Blood Cells Mol. Dis. 31: 102-111
122. Watanabe-Matsui, M., A. Muto, T. Matsui, et al. 2011. Heme regulates B-cell differentiation, antibody class switch, and heme oxygenase-1 expression in B cells as a ligand of Bach2. Blood 117: 5438-5448
123. White, C. A., J. Seth Hawkins, E. J. Pone, et al. 2011. AID dysregulation in lupus-prone MRL/Fas lpr/lpr mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4. Autoimmunity 44: 585-598
124. Hsu, H. C., Y. Wu, P. Yang, et al. 2007. Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies. J. Immunol. 178: 5357-5365
125. Hsu, H. C., P. Yang, J. Wang, et al. 2008. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 9: 166-175
126. Hsu, H. C., P. Yang, Q. Wu, et al. 2011. Inhibition of the catalytic function of activation-induced cytidine deaminase promotes apoptosis of germinal center B cells in BXD2 mice. Arthritis Rheum. 63: 2038-2048
127. Jiang, C., J. Foley, N. Clayton, et al. 2007. Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J. Immunol. 178: 7422-7431
128. Jiang, C., M. L. Zhao, and M. Diaz. 2009. Activationinduced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis. Immunology 126: 102-113
129. Fish, E. N. 2008. The X-files in immunity: sex-based differences predispose immune responses. Nat. Rev. Immunol. 8: 737-744
130. Klein, S. L. 2012. Immune cells have sex and so should journal articles. Endocrinology 153: 2544-2550
131. Ackerman, L. S. 2006. Sex hormones and the genesis of autoimmunity. Arch. Dermatol. 142: 371-376
132. Pennock, J. W., R. Stegall, B. Bell, et al. 2009. Estradiol improves genital herpes vaccine efficacy in mice. Vaccine 27: 5830-5836
133. Whitacre, C. C. 2001. Sex differences in autoimmune disease. Nat. Immunol. 2: 777-780
134. Klein, S. L., A. Jedlicka, and A. Pekosz. 2010. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 10: 338-349
135. Cohen-Solal, J. F., V. Jeganathan, L. Hill, et al. 2008. Hormonal regulation of B-cell function and systemic lupus erythematosus. Lupus 17: 528-532
136. Fairweather, D., S. Frisancho-Kiss, and N. R. Rose. 2008. Sex differences in autoimmune disease from a pathological perspective. Am. J. Pathol. 173: 600-609
137. Cohen-Solal, J. F., V. Jeganathan, C. M. Grimaldi, E. Peeva, and B. Diamond. 2006. Sex hormones and SLE: influencing the fate of autoreactive B cells. Curr. Top. Microbiol. Immunol. 305: 67-88
138. Grimaldi, C. M. 2006. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells. Curr. Opin. Rheumatol. 18: 456-461
139. Lee, T. P., and B. L. Chiang. 2012. Sex differences in spontaneous versus induced animal models of autoimmunity. Autoimmun. Rev. 11: A422-A429
140. Heldring, N., A. Pike, S. Andersson, et al. 2007. Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 87: 905-931
141. Pauklin, S., I. V. Sernandez, G. Bachmann, A. R. Ramiro, and S. K. Petersen-Mahrt. 2009. Estrogen directly activates AID transcription and function. J. Exp. Med. 206: 99-111
142. Mai, T., H. Zan, J. Zhang, et al. 2010. Estrogen receptors bind to and activate the promoter of the HoxC4 gene to potentiate HoxC4-mediated AID induction, immunoglobulin class-switch DNA recombination and somatic hypermutation. J. Biol. Chem. 285: 37797-37810
143. McInnes, I. B., and G. Schett. 2011. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365: 2205-2219
144. Xu, X., H. C. Hsu, J. Chen, et al. 2009. Increased expression of activation-induced cytidine deaminase is associated with anti-CCP and rheumatoid factor in rheumatoid arthritis. Scand. J. Immunol. 70: 309-316
145. Okazaki, I. M., H. Hiai, N. Kakazu, et al. 2003. Constitutive expression of AID leads to tumorigenesis. J. Exp. Med. 197: 1173-1181
146. Parsa, J. Y., W. Basit, C. L.Wang, et al. 2007. AID mutates a non-immunoglobulin transgene independent of chromosomal position. Mol. Immunol. 44: 567-575
147. Feldhahn, N., N. Henke, K. Melchior, et al. 2007. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells. J. Exp. Med. 204: 1157-1166
148. Nagaoka, H., T. H. Tran, M. Kobayashi, M. Aida, and T. Honjo. 2010. Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity. Int. Immunol. 22: 227-235
149. Qin, H., K. Suzuki, M. Nakata, et al. 2011. Activationinduced cytidine deaminase expression in CD4 T cells is associated with a unique IL-10-producing subset that increases with age. PLoS One 6: e29141
150. Rossi, D., E. Berra, M. Cerri, et al. 2006. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma. Haematologica 91: 1405-1409
151. Casellas, R., A. Yamane, A. L. Kovalchuk, and M. Potter. 2009. Restricting activation-induced cytidine deaminase tumorigenic activity in B lymphocytes. Immunology 126: 316-328
152. Klemm, L., C. Duy, I. Iacobucci, et al. 2009. The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. Cancer Cell 16: 232-245
153. Strout, M. P., and D. G. Schatz. 2009. Imatinib resistance and progression of CML to blast crisis: somatic hypermutation AIDing the way. Cancer Cell 16: 174-176
154. Pérez-Durán, P., V. G. de Yebenes, and A. R. Ramiro. 2007. Oncogenic events triggered by AID, the adverse effect of antibody diversification. Carcinogenesis 28: 2427-2433
155. Okazaki, I. M., A. Kotani, and T. Honjo. 2007. Role of AID in tumorigenesis. Adv. Immunol. 94: 245-273
156. Matsumoto, Y., H. Marusawa, K. Kinoshita, et al. 2010. Up-regulation of activation-induced cytidine deaminase causes genetic aberrations at the CDKN2b-CDKN2a in gastric cancer. Gastroenterology 139: 1984-1994
157. Endo, Y., H. Marusawa, and T. Chiba. 2011. Involvement of activation-induced cytidine deaminase in the development of colitis-associated colorectal cancers. J. Gastroenterol. 46(Suppl 1): 6-10
158. Shinmura, K., H. Igarashi, M. Goto, et al. 2011. Aberrant expression and mutationinducing activity of AID in human lung cancer. Ann. Surg. Oncol. 18: 2084-2092
159. Babbage, G., C. H. Ottensmeier, J. Blaydes, F. K. Stevenson, and S. S. Sahota. 2006. Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines. Cancer Res. 66: 99-111
160. Macduff, D. A., M. S. Neuberger, and R. S. Harris. 2006. MDM2 can interact with the C-terminus of AID but it is inessential for antibody diversification in DT40 B cells. Mol. Immunol. 43: 1099-1108
161. Demorest, Z. L., D. A. MacDuff, W. L. Brown, et al. 2010. The interaction between AID and CIB1 is nonessential for antibody gene diversification by gene conversion or class switch recombination. PLoS One 5: e11660